
To own Nutrien, you need to be comfortable with a fertilizer producer that leans heavily on potash and nitrogen and faces slow top line expectations plus forecast earnings pressure over the next few years. The Trinidad nitrogen shutdown looks operationally contained in the near term, since 2026 guidance already assumed zero production from that facility.
The more interesting short term angle is execution on North American nitrogen reliability and debottleneck projects, because that is where free cash flow and returns on invested capital are being tested. The biggest risk right now is that softer fertilizer pricing or higher regulatory and environmental costs squeeze margins while the business also carries a meaningful debt load.
The October 5, 2026 announcement to indefinitely shut the Trinidad Nitrogen operations is the clearest recent signal of where Nutrien is putting its effort. Management is aligning the nitrogen portfolio toward regions where natural gas supply is more predictable and where incremental volume can come from efficiency projects rather than large new builds.
For catalysts, you are really watching whether the North American nitrogen assets can sustain volumes and cost per ton that support the firm’s free cash flow story while analysts still expect earnings to decline about 2.8% a year over three years. Any wobble in uptime, gas availability, or project execution would amplify existing concerns about slow revenue growth and low forecast return on equity.
Nutrien's analyst narrative points to forecast revenue of $28.0b and consensus earnings of $2.1b by 2029. Revenue is assumed to be fairly flat, and earnings are expected to move from $2.4b today to $2.1b, a decline of $0.3b over that period.
Uncover why Nutrien's fair value indicates a 6% potential upside to its current price, which could narrow quickly.
One alternative view on Nutrien leans heavily on the risk that earnings slide more than the baseline storyline suggests. The most pessimistic analysts were already penciling in revenue of about $26.1b and profit of $1.7b by 2029, compared with $2.4b today. The Trinidad decision could nudge those expectations again, so treat this as a cue to compare multiple narratives before you commit fresh capital.
Explore 4 other Nutrien fair value estimates, including one that suggests it could be worth just CA$97.46.
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
If the Nutrien story has sharpened your thinking about risk, balance sheets, and earnings power, use that same lens to scan a wider field of opportunities with the Simply Wall St Screener.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com